DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
What to expect on Zepbound (tirzepatide) from your first injection through maintenance: appetite changes, side-effect onset, and weight-loss milestones.
First weekly injection at 2.5 mg. Early appetite reduction reported by some users within 48 hours. No significant weight change yet.
Satiety changes more pronounced. Users typically lose 2-4 lbs by week 4 on starting dose.
Titration through 5 → 7.5 → 10 → 12.5 mg. Weight loss accelerates. SURMOUNT-1 cohort lost ~10% by week 16.
Maintenance at 10, 12.5, or 15 mg. SURMOUNT-1 averaged 15-22% by month 9 depending on dose.
SURMOUNT-1 averaged 20.9% at 72 weeks on 15 mg. Maintenance phase begins.
Editorial summary based on pivotal trial titration schedules and real-world reports. Individual timelines vary. Not medical advice.